Today, as part of a national initiative funded by The John A. Hartford Foundation (JAHF), the national, independent nonprofit FAIR Health launched a new shared decision-making tool for Alzheimer’s disease that features clinical information for self-care and drug therapy options, as well as related cost information.
Lilly challenges Wegovy dominance in weight loss market with FDA approval – Pharmaceutical Technology
Lilly has set Zepbound’s list price in the US at $1,059.87, 20% less than that for Wegovy. Image Credit: Tada Images / Shutterstock. Eli Lilly’s
November 9, 2023